Perrigo Company PLC (PRGO)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NYSE
Market Cap: $2.25B
Last updated: Nov 17, 2026 at 11:06 AM ET
Perrigo Company PLC (PRGO) Competitors
The companies most similar to Perrigo Company are Prestige Brand Holdings (PBH), Pacira BioSciences (PCRX) and Phibro Animal Health (PAHC). Perrigo Company trades at 7.0x earnings, against a median of 10.7x for the 11 of these companies with a P/E. By market cap, Perrigo Company ranks 4th of the 13 companies on this page; Indivior PLC Ordinary Shares (INDV) is the largest at $4.28B.
Peer Comparison
PRGO's ROIC of -26.3% is below the peer median of 8.1%, and its revenue growth of -5.2% is below the median of 13.3%. It yields 7.17%, while the median peer pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Perrigo Company (PRGO) | $2.25B | 7.0x | 0.6x | -43.3% | -26.3% | -5.2% | 7.17% |
| Prestige Brand Holdings Inc (PBH) | $2.19B | 10.7x | 2.0x | 13.3% | 5.0% | 22.7% | 0.00% |
| Pacira BioSciences, Inc. (PCRX) | $1.46B | 20.0x | 2.0x | 5.1% | 4.2% | -1.6% | 0.00% |
| Phibro Animal Health Corporation (PAHC) | $1.46B | 10.7x | 0.9x | 6.7% | 11.7% | 6.3% | 1.37% |
| Eton Pharmaceuticals Inc (ETON) | $1.84B | 36.7x | 13.0x | 35.3% | 37.0% | 157.9% | 0.00% |
| BioCryst Pharmaceuticals Inc (BCRX) | $1.96B | 4.4x | 2.0x | -37.4% | 24937.1% | 13.1% | 0.00% |
| Bausch Health Companies Inc (BHC) | $3.13B | 1.7x | 0.3x | -7.6% | 6.3% | 9.7% | 0.00% |
| Xeris Pharmaceuticals Inc (XERS) | $3.04B | 139.2x | 8.2x | -1.8% | 15.5% | 44.2% | 0.00% |
| Indivior PLC Ordinary Shares (INDV) | $4.28B | 6.6x | 2.4x | 32.8% | 109.0% | 13.4% | 0.00% |
| Collegium Pharmaceutical Inc (COLL) | $786.83M | 3.7x | 1.0x | 4.7% | 8.1% | 3.3% | 0.00% |
| Cronos Group Inc (CRON) | $1.24B | 28.4x | 5.6x | 28.0% | N/A | 74.6% | 0.00% |
| Amphastar P (AMPH) | $1.25B | 10.3x | 1.7x | 13.3% | 7.9% | 8.2% | 0.00% |
| Harrow Health Inc (HROW) | $1.13B | N/A | 3.6x | -9.4% | -0.3% | 38.6% | 0.00% |
| Peer median | $1.65B | 10.7x | 2.0x | 5.9% | 8.1% | 13.3% | 0.00% |
Similar Companies
These are the 12 companies most similar to Perrigo Company, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Drug Manufacturers - Specialty & Generic.
| Company | About | Peers |
|---|---|---|
| Prestige Brand Holdings Inc (PBH) | Prestige Consumer Healthcare Inc., develops, manufactures, markets, distributes and sells over-the-counter (OTC) healthcare products in the United States... | PBH competitors |
| Pacira BioSciences, Inc. (PCRX) | Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare professionals and their patients in the United... | PCRX competitors |
| Phibro Animal Health Corporation (PAHC) | Phibro Animal Health Corporation develops, manufactures and supplies a range of mineral nutrition and animal health products for livestock primarily... | PAHC competitors |
| Eton Pharmaceuticals Inc (ETON) | Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and marketing pharmaceuticals for rare diseases. | ETON competitors |
| BioCryst Pharmaceuticals Inc (BCRX) | BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers oral and small molecule drugs. The company is headquartered in Durham, North Carolina. | BCRX competitors |
| Bausch Health Companies Inc (BHC) | Bausch Health Companies Inc. develops, manufactures and markets a range of pharmaceutical... | BHC competitors |
| Xeris Pharmaceuticals Inc (XERS) | Xeris Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and markets ready-to-use injectable and infusible drug formulations. | XERS competitors |
| Indivior PLC Ordinary Shares (INDV) | Indivior PLC, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence... | |
| Collegium Pharmaceutical Inc (COLL) | Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and markets pain management medications. | COLL competitors |
| Cronos Group Inc (CRON) | Cronos Group Inc. is a cannabinoid company. The company is headquartered in Toronto, Canada. | CRON competitors |
| Amphastar P (AMPH) | Amphastar Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation... | AMPH competitors |
| Harrow Health Inc (HROW) | Harrow Health, Inc. is an ophthalmology-focused healthcare company. The company is headquartered in San Diego, California. | HROW competitors |
Frequently Asked Questions About PRGO
Who are Perrigo Company's main competitors?
The companies most similar to Perrigo Company include Prestige Brand Holdings (PBH), Pacira BioSciences (PCRX), Phibro Animal Health (PAHC), Eton Pharmaceuticals (ETON) and BioCryst Pharmaceuticals (BCRX), listed from the closest match.
Who is Perrigo Company's biggest competitor?
Indivior PLC Ordinary Shares (INDV) is the largest of the similar companies at $4.28B; Prestige Brand Holdings (PBH) is the closest match by business profile, size, sector and industry.
How does PRGO stock compare with its competitors?
PRGO's P/E is 7.0x against a peer median of 10.7x; its P/S is 0.6x against a peer median of 2.0x; its net margin is -43.3% against a peer median of 5.9%.
Which of Perrigo Company's competitors pays a higher dividend?
Perrigo Company has a forward dividend yield of 7.17%. None of the similar companies with available yields has a higher forward dividend yield.
Is Perrigo Company bigger than its competitors?
No. Perrigo Company is 4th by market cap among the 13 companies on this page; the largest is Indivior PLC Ordinary Shares (INDV) at $4.28B.
PRGO pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors